Meta-Analysis
Copyright ©The Author(s) 2022.
World J Meta-Anal. Jun 28, 2022; 10(3): 186-194
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.186
Table 1 Actual elevated alanine aminotransferase levels cited in patients with chronic hepatitis B
Ref.
Actual elevated ALT levels
Kim et al[5]Above normal levels
Du et al[6]Above normal levels
Choi et al[7]Above normal levels
Wen et al[8]≥ 25 IU/L
Hann et al[11]Elevated
Chen et al[12]≥ 45 IU/L
Kumada et al[13]Absence of persistently normal ALT levels
Chen et al[14]Above normal levels
Ishiguro et al[15]≥ 30 IU/L
Ando et al[16]≥ 23 IU/L
Yamada et al[17]≥ 40 IU/L
Table 2 Actual elevated alanine aminotransferase levels cited in patients with chronic hepatitis C
Ref.
Actual elevated ALT levels
Ishiguro et al[15]≥ 30 IU/L
Chen et al[18]≥ 45 IU/L
Sun et al[19]Elevated
Tanaka et al[20]Elevated
Kumada et al[21]> 20 IU/L
Ito et al[22]> 35 IU/L
Suruki et al[23]> 35 IU/L
Lee et al[24]Always ≥ 45 IU/L
Table 3 Hazard ratio for developing hepatocellular carcinoma for each item in various reports of patients with chronic hepatitis B virus infection
Ref.
Sex
Age
HBV-DNA
ALT
AFP
Presence of cirrhosis
HBV genotype
Alcohol use
Tabaco
DM
Kim et al[5]2.7821.0800.9862.6412.9552.1052.00
Du et al[6]2.943.302.552.45
Choi et al[7]1.671.051.021.541.211.54
Wen et al[10]1.935.341.93
Hann et al[11]1.212.60
Chen et al[12]3.125.757.9612.05 (Type C)
Kumada et al[13]6.0115.1253.9396.77918.033
Chen et al[14]1.22.01.61.72.31.9
Ishiguro et al[15]10.52.183
Ando et al[16]2.2003.3951.4421.9141.967
Yamada et al[17]1.445.8675.59
Average2.523.152.2123.376.42
Table 4 Hazard ratio for developing hepatocellular carcinoma in each item in various reports of patients with chronic hepatitis C virus infection
Ref.
Sex
Age
ALT
AFP
Presence of cirrhosis
DM
HCV-genotype
Ishiguro et al[15]11.410.5
Chen et al[18]1.655.834.433.46
Sun et al[19]6.57.7
Tanaka et al[20]2.634.476.23
Kumada et al[21]2.426.26310.003
Ito et al[22]1.4482.1871.9166.5
Suruki et al[23]
Lee et al[24]2.8 (HCV-1)
Average5.4865.877